Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from enGene Holdings ( (ENGN) ) is now available.
On June 4, 2025, enGene USA, Inc., a subsidiary of enGene Holdings Inc., entered into a lease agreement for office space in Boston, Massachusetts. The lease, which begins on June 19, 2025, spans five years and five months, with an initial monthly rent of $168,982, increasing over time. The parent company has guaranteed the lease, ensuring all financial and operational obligations are met, which could strengthen enGene’s presence in the U.S. market and indicate a strategic expansion.
The most recent analyst rating on (ENGN) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on enGene Holdings stock, see the ENGN Stock Forecast page.
Spark’s Take on ENGN Stock
According to Spark, TipRanks’ AI Analyst, ENGN is a Neutral.
enGene Holdings shows significant financial challenges, with no revenue generation and persistent losses impacting both income and cash flow statements. Technical indicators suggest bearish momentum, with the stock underperforming key moving averages. The valuation is further hampered by a negative P/E ratio and absence of dividends. These factors collectively result in a low overall stock score, highlighting the company’s urgent need to establish a revenue model and improve operational efficiency.
To see Spark’s full report on ENGN stock, click here.
More about enGene Holdings
enGene Holdings Inc. operates in the biotechnology industry, focusing on developing innovative gene therapies. The company is based in British Columbia, Canada, and has a subsidiary, enGene USA, Inc., in Delaware.
Average Trading Volume: 60,002
Technical Sentiment Signal: Sell
Current Market Cap: $193M
Learn more about ENGN stock on TipRanks’ Stock Analysis page.